Feature Healthcare Stocks Top News Analyst and Research Coverage Bullish on Cardiol Therapeutics Cardiol Therapeutics Inc. (Nasdaq: CRDL) (TSX: CRDL) has in some ways burst… Robin LeffertsMay 1, 2024
Healthcare Stocks Cardiol Therapeutics Announces Year-End 2023 Update on Operations Completed patient enrollment in the Phase II MAvERIC-Pilot study evaluating CardiolRx™ in… Ryan AllwayApril 2, 2024
Feature Healthcare Stocks Top News The Impact of Positive Phase 2 Trial Results on a Smaller Company A few weeks back, we covered the effect an Orphan Drug Designation… Robin LeffertsMarch 12, 2024
Healthcare Stocks Cardiol Therapeutics Completes Patient Enrollment in its Phase II MAvERIC-Pilot Study Investigating CardiolRx(TM) for Recurrent Pericarditis Topline Results Expected in Q2 2024 This is a Designated News Release.… Ryan AllwayFebruary 21, 2024
Healthcare Stocks Top News Cardiol Therapeutics Granted Orphan Drug Designation for its Lead Drug Candidate for the Treatment of Pericarditis Designation Based on Pre-Clinical Data and Initial Clinical Data from the Company’s… Ryan AllwayFebruary 15, 2024
Feature Healthcare Stocks Top News The Impact of Orphan Drug Development on a Smaller Company Orphan drugs treat conditions with less than 200,000 patients annually in the… Robin LeffertsFebruary 6, 2024
Feature Healthcare Stocks Top News Distinguished Health Centers and Experts Lead Recurrent Pericarditis, Acute Myocarditis Clinical Trials Any clinical trial program relies heavily on its administrators, advisors, and designers.… Robin LeffertsJanuary 16, 2024
